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Abstract
The increasing threats of emerging and reemerging infectious disease outbreaks 
demand research and development (R&D) of effective and fit-for-all-purpose 
tools and technologies for international public health security. Recent advances 
in biomedical engineering, mostly related to the convergence of communication 
and network technology in health, i.e., mobile health with microfluidic Lab-on-
a-Chip technology can improve the international public health crises and employ 
in international public health security. Lab-on-a-Chip technology is now com-
monly found in most research centers, hospitals, and clinics where health care 
infrastructure is weak, and access to quality and timely medical care is challenging. 
Microfluidic devices—also known as Lab-on-a-Chip (LoC)—are an alternative for 
accessible, cost-effective, and early detection medical trials. The mHealth-based 
microfluidic LoC technology has been under rapid development, and they are 
becoming influential tools in a wide range of biomedical research and international 
public health applications. The perspective in this chapter demonstrates a poten-
tially transformative opportunity for the deployment of mHealth with LoC with 
the fabrication protocols and their potential for strengthening and improving the 
international public health security. This attempt is not conclusive and exhaustive, 
and it is anticipated that such a discussion will enable the exchange of ideas between 
biomedical engineering, microfluidic LoC technology professionals, international 
public health, and health security experts.
Keywords: biomedical engineering, mobile health (mHealth), microfluidic,  
Lab-on-a-Chip, international public health security
1. Introduction
Emerging and reemerging infectious diseases, and their pandemic potential, 
pose a challenge to international public health security in the twenty-first century 
that cannot be overlooked [1]. Though the historical threat to international secu-
rity by epidemic diseases is not new, the threat has increased in recent years and 
is growing rapidly. Infectious disease emergencies can arise with little notice and 
have serious detrimental and lasting effects on international public health security 
[2]. In the past century, we have seen international health emergencies such as the 
Contemporary Developments and Perspectives in International Health Security - Volume 1
2
emergence of the deadly SARS coronavirus, and the 2013–2016 Ebola epidemic 
in West Africa [4] that resulted in more than 28,000 cases and 11,000 deaths and 
had devastating impacts on international health security, as just a few exemplar. 
Correspondingly, before 1970, only nine countries had experienced severe dengue 
epidemics; however, at present, dengue fever has affected more than 100 coun-
tries in tropical and subtropical regions [5]. It was estimated by the World Health 
Organization (WHO) that approximately 150 million dengue infections occur 
annually, with a 30-fold increase in global incidence observed over the past 50 years 
[6]. Reemergence of mosquito-borne infections such as chikungunya, zika, more 
virulent forms of malaria, and new more severe forms of viral respiratory infec-
tions has also evolved in recent years. Historically, literature on health and security 
has been scarce, and only in the past few years, a body of literature on health and 
security emerged. At the nexus of health and security lies many poignant examples 
of the growing threat of biological weapons, the negative impact of naturally 
occurring infectious diseases, and the migration and proliferation of emerging and 
reemerging infectious diseases to nonendemic areas that fabricate a strong case for 
including health concerns in the international public health security debate. Though 
international public health and health security traditionally occupied separate 
domains, in recent years, the imperative fusion between them has been recognized 
by policymakers and security and defense analysts in both developed and develop-
ing countries [7].
1.1 International public health security
International public health security is pretty new topic, and it has recently taken 
on a new urgency for policymakers and health security and defense analysts. The 
field of international public health security is an important one, closely related 
to people’s lives, and essential for societies and countries to grow and develop. 
Traditionally, environmental health emergencies, humanitarian emergencies 
including natural and human-made disasters, conflicts and complex emergencies, 
civil strife, or human health rights violations constitute what has been considered 
the main threat to health security [8, 9]. Correspondingly, pandemics and epidem-
ics also killed countless millions throughout human history. The 1918 flu pandemic 
killed 50–100 million, which is more than the combined total casualties of World 
War I and II [10]. In our time, highly virulent infectious diseases have not only 
repeatedly swept through human societies, causing death, economic chaos, and 
political and social disorders, but also placed sudden and intense demands on inter-
national public health security. In many countries, millions of people are suffering 
from avoidable health problems. Improvements to health and medical services 
are therefore emerging as a major priority in many countries, where many people 
continue to suffer due to common diseases such as HIV/AIDS, diabetes, and cancer, 
including tropical diseases, such as malaria, dengue fever, respiratory diseases, 
etc. [11]. Today, such diseases remain a serious international public health threat. 
According to the world health report released by the World Health Organization 
(WHO), noncommunicable diseases (NCDs) are responsible for approximately 
71% of global deaths, with the leading causes being lower respiratory infections, 
HIV/AIDS, diarrheal diseases, and tuberculosis (TB) [12]. Table 1 illustrates the 
top 10 leading causes of death in three categories, i.e., worldwide, low-income 
countries, and high-income countries. Many diseases need immediate attention 
and require new health technologies for their prevention and on-time diagnosis. 
One such promising solution can now be thought of because of the recent advances 
in the mobile health (mHealth) and Lab-on-a-Chip (LoC) technologies. On-going 
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research in these technological fields leads to the rapid emergence of such devices 
that can prove to be very useful for improving the international public health and 
employed in health security.
1.2 Mobile health (mHealth)
mHealth is defined as the use of mobile communication and network technolo-
gies, i.e., smartphones, tablet PCs, and PDAs, for health service [13]. In broad, it is the 
employ of handy gadgets that are having ability of improving health and quality of 
care. mHealth is an evolving and swiftly rising field that holds the potential to play an 
imperative part in the transformation of healthcare and increase the quality of care. 
mHealth cover a range of hi-tech solutions, such as measure of vital signs, i.e., heart 
beating rate, blood sugar level, blood pressure, temperature of body, activities of 
brain, etc. [14]. The widespread use of mobile devices has offered a novel approach to 
address many health-related challenges. The mobile devices and mobile networks can 
be present in resource-limited regions where medical equipments are either unavail-
able or insufficiently portable for wide deployment. According to the data released by 
International Telecommunication Union (ITU), 96.8% of the people worldwide are 
mobile-cellular telephone subscribers, and 62.9% of them are active mobile-broad-
band users [15, 16]. The statistic in Figure 1 shows the total number of mobile phone 
users worldwide from 2015 to 2020. In 2019, the number of mobile phone users was 
forecast to reach 4.68 billion [17]. The penetration of mobile devices in many regions 
has surpassed many other infrastructures, i.e., electricity, paved roads, and advanced 
healthcare resources. Such increasing accessibility of mobile devices can provide 
opportunities to transform the international public health and health security.
Smartphones have been increasingly adapted in various healthcare applica-
tions in recent years [18], and according to applications, the use of mHealth-based 
healthcare practice can be divided into two categories, as demonstrated in Table 2 
in vivo test and in vitro test. Similarly, out-of-clinic smartphone use covers most 
of the software applications and the corresponding devices, external wearable 
sensors, for the daily monitoring of the health and wellness. On the other hand, 
Rank Worldwide Low-income countries High-income countries
1 Heart disease Lower respiratory 
infections
Heart disease
2 Stroke Diarrheal diseases Stroke
3 Chronic obstructive 
pulmonary disease
Heart disease Alzheimer’s disease
4 Lower respiratory infections HIV/AIDS Lung cancers
5 Alzheimer’s disease Stroke Chronic obstructive pulmonary 
disease
6 Lung cancers Malaria Lower respiratory infections
7 Diabetes Tuberculosis Colon caners
8 Road injury Preterm birth 
complications
Diabetes
9 Diarrheal diseases Birth asphyxia and trauma Kidney diseases
10 Tuberculosis Road injury Breast caner
Table 1. 
The top 10 leading causes of death [12].
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the in-clinic applications of smartphones involve the diagnostics of specific types 
of diseases and are supposed to help make clinical decisions [19, 20]. For example, 
a single-channel electrocardiograph (ECG) can be integrated at the back case of 
an iPhone and a plug-and-play blood pressure monitor can wirelessly link to a 
smartphone. Smartphones, equipped with a computer-like platform and vari-
ous types of sensors, have several properties promoting their uses in in vivo and 
in vitro test [14]. This confirms that mobile and network technologies are becom-
ing widely accessible even in resource-limited areas lacking adequate healthcare 
facilities.
1.3 Microfluidic Lab-on-a-Chip technology
The idea of a technology for a device unifying data acquisition and measurement 
together with sensing and analysis and a response to analysis result was brought 
into practice for the first time in 1979. By the late 80s and early 90s, Lab-on-a-Chip 
technology experienced a fast development of total analysis microsystems (uTAS) 
Figure 1. 
The number of mobile phone users worldwide from 2015 to 2020 [17].
Category Explanation Examples
In vivo test Test that does not require 
sample consumption; biological 
signals are converted to 
electrical signals by various 
sensors.
Test with 
built-in sensor
Use the built-in sensors, such as 
camera, to collect human body or 
environmental signals
Test with extra 
sensor
Use extra sensors, such as an 
ultrasound probe, to collect 
human body or environmental 
signals
In vitro 
test
Test that requires sample 
consumption; biological 
components or organisms are 
detected from samples, such as 
blood, sweat, etc.
Tube strip 
and specimen 
inspection
Take a specimen of bodily fluid 
and directly inspect the result 
using the built-in camera or 
microscope connected to a 
smartphone
Microfluidic 
testing
Take a specimen of bodily fluid 
and use microfluidic technique to 
perform complicated biochemical 
tests and visualize the result using 
a smartphone
Table 2. 
Categories of smartphone-based test [14].
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[21–24]. These systems were formerly designed for improving chemical separa-
tion techniques, particularly capillary electrophoresis, and were later applied in 
experiments with biological materials [25], DNA and RNA, cells and bacteria, 
proteins, etc., motivated by the potential market for biomedical research [26]. 
Microfluidic-based biosensors, primarily dedicated to the detection of biomolecules 
such as proteins, enzymes, peptides, and DNA, are proposed in the biomedical field 
as tools to monitor cell behavior on a miniaturized scale, with high sensitivity and 
resolution and low costs [27]. By detecting cellular analytes, electrical activities, 
and chemical and physical signals transmitted by the cells, microfluidic-based 
biosensors provided insights into cellular activities and responses in real time [28]. 
As a result, microfluidic-based biosensors—also known as Lab-on-a-Chip (LoC) 
devices—became more and more popular.
LoC devices are promoted for biomedical, biotechnology, chemical, and envi-
ronmental monitoring applications as a response to the necessity of time effec-
tive, low cost, automated laboratory tests by integrating one or more functions 
in one miniaturized device, such as sample transport, reagent mixing, heating, 
evaluation, analysis, and synthesis [29–32]. LoC technology integrates microflu-
idic and electronic components onto the same chip for the development of hybrid 
devices to reduce laboratory processes in a manner competitive to bench-top 
instruments [22]. LoC technology emphasizes integration, chip programmabil-
ity, increased sensitivity, minimal reagent consumption, sterilization, and 
efficient sample detection and separation. A typical LoC device contains micro-
channels, which not only allow liquid samples to flow inside the chip, but also 
integrates measuring, sensing, and actuating components such as microvalves, 
micromixers, microelectrodes, thermal elements, and optical apparatuses [23]. 
Microfluidic-based LoC devices have also become very attractive nowadays as 
they force the development of personalized devices for point-of-care treatments, 
and enable the fabrication of the next generation of portable and implantable 
bioelectronic devices [24]. Due to their biosensing capability and embedding con-
cept, the microfluidic-based LoC systems are attractive platforms for developing 
implantable bioinspired sensors that can be integrated with communication and 
network technology [33].
2. Methodology: technology identification process
Because international public health security is a relatively new topic of interest 
and inquiry, one would not expect to find a well-established body of literature sur-
rounding this theme. However, to identify potentially relevant technology solutions 
for international public health security, I conducted a horizon scan to understand 
the mHealth-based microfluidic Lab-on-a-Chip technology that could benefit 
international public health security. In order to identify potential transformative 
technology, I reviewed non-peer-reviewed gray literature, technology reviews, and 
peer-reviewed scientific literature for recent development in the LoC technology 
and fabrication protocols. Searches were conducted through PubMed, Google, 
Google Scholar, and Web of Science databases.
3. Fabrication protocols and chip materials
There are many fabrication protocols and materials for prototyping LoCs. A 
design framework can be used with these fabrication materials and methods in 
recourse-limited settings, discussed in the following section.
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3.1 Photolithography
Photolithography is one of the earliest and still one of the most popular methods 
for fabricating LoCs. The photolithography and etching method for fabricating 
mask and LoCs relies on the traditional photo developing method. The process 
involves using negative or positive photoresists. Photoresists are exposed to high 
intensity UV-wavelengths through masks and spin coated. In photolithography, 
there are mask and mask-less methods. Mask-less photolithography can be achieved 
by methods whereby light is spatially modulated and light patterns can be manipu-
lated at every pixel. In photolithography, before etching with chemicals, a UV resist 
can be used to spin coat chemicals and focused UV light can be beamed onto the 
photoresist [34].
3.2 Softlithography
In softlithography, the reverse master is designed and fabricated in such a way as 
to have protruding patterns on its surface. It can be the positive or negative image of 
a target LoC. Silicon, PMMA, or a chemical-coated PDMS can be made to bear the 
master image. One of the benefits of softlithography is that it can be used to fabri-
cate LoCs with three-dimensional microfluidics channels and also to form micro-
structures, including channels, and submacrostructures, including cell-culture 
chambers [29, 30, 35]. Softlithography technique is convenient, straightforward 
to apply, accessible to a wide range of users, and low-cost nonphotolithographic-
based approach for micro and nanofabrication. Some softlithography techniques 
are: microcontact printing (μCP), microtransfer molding (μTM), replica molding 
(REM), micromolding in capillaries (MIMIC), and solvent-assisted micromolding 
(SAMIM). Table 3 compares the advantages and disadvantages of conventional 
photolithography and softlithography [29].
3.3 Microembossing
Microembossing, also known as microtransfer molding or hot-embossing, is 
the process by which the configuration of microfluidic channels is transferred onto 
Photolithography Softlithography
Definition of patterns Rigid photomask Elastomeric stamp or mold
Materials that can be 
patterned directly
Photoresists Photoresists
SAMs on Au and SiO2 SAMs on Au, Ag, Cu, GaAs, Al, Pd, and 
SiO2
Precursor polymers
Polymer beads
Sol-gel materials
Conducting polymers
Colloidal materials
Organic and inorganic salts
Biological macromolecules
Surfaces and structures that 
can be patterned
Planar surface
Two-dimensional 
structures
Both planar and nonplanar
Both two-dimensional and three-
dimensional structures
Resolution 100 nm From 30 nm to 1 μm
Table 3. 
Comparison between photolithography and softlithography [21–24, 29, 30, 33–35].
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the thermoplastic material. The polymer material is pressed with a heated barrel 
so that the material becomes soft and molted. By applying pressure and heat onto 
the polymer sheet, the shape is then transferred from metal press to the sheet. To 
transfer microscale patterns inexpensively, the hot-embossing method can be used. 
Such a method is affordable, assessable, and available even to resource-constrained 
laboratories for the production of disposable LoCs [31].
3.4 Injection molding
In injection molding fabrication protocol, the injection of molten thermoplastic 
involves under high pressure into a heated closed master mold, followed by cooling 
until the thermoplastic solidifies, and subsequent demolding the replica from the 
master mold. For industrial scale manufacturing of macroscopic objects in ther-
moplastics that has been adopted for micromanufacturing, injection molding is a 
well-established technique [32].
3.5 PDMS Lab-on-a-Chip
PDMS (polydimethylsiloxane) is a straightforward, adaptable, and low-cost 
polymer that can be used to fabricate LoC by the softlithography. Research labora-
tories commonly use PDMS for LoC prototyping, which is one of the least resource 
demanding fabricating methods. PDMS is also broadly utilized on the grounds that 
it is simple and shabby to create PDMS LoCs [36]. Moreover, LoC made of PDMS 
takes preferred standpoint of the simple mix of shudder miniaturized scale valves 
for quick stream switch and penetrability of air for cell-and-tissue-culture-LoCs 
[37]. Commonly utilized for LoCs prototyping, PDMS demonstrates extreme 
impediments for modern generation. The properties of PDMS are surprisingly 
close to that could be obtained from glass and plastic. The cross-linking of many 
of these polymer chains makes a structure that is flexible and reversibly deform-
able. Table 4 summarizes the physical properties of PDMS, and Table 5 compares 
polymer and glass as substrate for chemical and biomedical applications [36]. 
Many of properties demonstrate that the PDMS is very desirable for fabricating 
microfluidic LoCs.
3.6 Thermoplastic-polymers Lab-on-a-Chip
Irrespective of the opportunity that it is a little bit more uncertain and expensive 
to actualize than PDMS, thermoplastics are great contender for the manufacture of 
LoCs. Thermoplastic polymers are generally utilized by specialists to manufacture 
LoCs. Polymethyl methacrylate (PMMA), given its transparency, can be used as the 
positive tone photoresist in X-ray lithography and e-beam lithography processes 
[38]. Cyclic-olefin Copolymer (CoC) polymer is a popular fabrication material for 
various applications, including lenses and medical devices. CoC can also be used for 
the 3D printing of microfluidic LoC devices. PolyCarbonate (PC), which is more 
inert to chemical solvent than PDMS therefore, can be useful for some LoC applica-
tions where PDMS are not suitable for the required LoC applications. However, 
fabricating LoCs using PC requires investment intensive high-pressure embossing 
micromachining tools. Poly vinyl alcohol (PVA) is used for fabricating sophisti-
cated LoCs with three-dimensional polymer microstructures. PVA can be dissolved 
in water but not in solvents, so they can be used as sacrificial materials. One more 
type of polymer not directly used for fabricating LoCs but still useful for biomedi-
cal application is Parylene. Parylene allows the transmission of waves in the visible 
spectrum, and it is not porous and can be coated onto electronics to prevent it from 
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Polymers Glass
Manufacturing costs Lower costs than glass, especially in 
mass volume
More expensive to manufacture 
as fabrication process is more 
complex
Fabrication complexity Simple fabrication process Time-consuming and expensive, 
and usually wet chemistry is used
Clean room facilities Cleanroom environment is necessary Cleanroom facilities are required
Operation temperature Narrow range due to the low glass 
transition temperature
Wider range of operation 
temperature than polymer
Optical properties and 
fluorescence detection
Higher autofluorescence in the UV end 
of the spectrum and lower transparency 
than glass
Superior optical property than 
glass
Compatibility with 
organic solvents or 
strong acids
Generally not compatible with most 
organic solvents
Excellent resistance to solvents 
and acids
Permeability to gases Higher gas permeability relative to glass Does not met the gas permeability 
requirements for some biological 
applications
Geometrical flexibility More flexibility for geometrical designs 
with a wide selection of different cross-
sections; high aspect ratio and arbitrary 
wall angle
Limited to two-dimensional design 
due to isotropic nature of etching 
process. Less flexibility in cross-
sections than polymer
Table 5. 
Comparison between polymer and glass as the substrate of microfluidic LoC systems for biomedical and 
chemical applications [36].
Property Characteristic Consequence
Optical Transparent
UV cut-off = 240 nm
Optical detection from 240 to 1100 nm
Electrical Insulating
Breakdown voltage = 2 × 107 
v/m
Allows embedded electrical circuits
Electrophoresis possible on contained fluid
Mechanical Elastomeric
Young’s modulus typically 
750 kPa
Conforms to surfaces
Facilitates release from molds
Thermal Insulator
Thermal conductivity  
0.2 W/(m K)
Thermal expansion coeff. 
310 μm/(m°C)
Can withstand 200°C
Does not allow the dissipation of optical absorption 
heating or electrophoretic resistive heating
Can be autoclaved for sterilization
Permeability Impermeable to liquid water
Permeable to gases and 
nonpolar solvents
Contain aqueous solutions in channels; allow gas 
transport through material bulk
Incompatible with many organic solvent
Reactivity Inert
Oxidized by plasma exposure
Unreactive toward most reagents, including ethanol
Surface can be etched
Can be modified to be hydrophilic and also reactive 
toward silanes
Can be permanently bonded
Toxicity Nontoxic Can be implanted in vivo
Supports mammalian cell cultures
Table 4. 
Physical properties of PDMS [36].
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corroding and avoiding electrical short circuiting [34]. For specific applications, 
some exploration groups acquired great outcomes with thermoplastic-polymers 
LoCs, and since it is feasible to integrate microelectrodes into these polymers, 
thermoplastic polymers are having evident opportunity for the industrial develop-
ment of some LoCs [39].
3.7 Silicon and glass Lab-on-a-Chip
The earliest LoCs were fabricated in silicon, and it appears like a significant 
characteristic decision since smaller scale innovations depend on the micromachin-
ing of silicon [35]. These days’ scientists do not frequently utilize silicon for LoC, 
for the most part since silicon is costly, not optically nontransparent, and requires 
a spotless room. Moreover, the electrical conductivity of silicon makes it difficult 
to use for LoC operations. Still, silicon is relevant choice for the industrialization 
of some LoC applications. Analogous to silicon, glass is also the earliest fabrication 
material for LoCs. Glass is a hard material to fabricate chip but a useful material due 
to its inertness and transmutability of wavelengths in UV, IR, and visible regions 
[40]. However, fabricating LoCs in glass requires hazardous chemicals and lengthy 
time intervals, expensive facilities. From an exploration perspective, the creation of 
glass LoCs requires clean rooms and specialists with solid information of microfab-
rication techniques.
4. Advantages of microfluidic Lab-on-a-Chip technology
Globally, every country confronts parallel challenges in keeping its inhabitants 
healthy and preventing the cross-border spread of infectious diseases. Biomedical 
engineers, synthetic chemists, and biologists along with public health profession-
als are evaluating the potentiality of microfluidic LoC technology in the context 
of international public health security. In recent years, certain applications have 
emerged, from the detection of infectious diseases to diagnostics for international 
public health [41]. Several on-chip clinical assessments have also appeared include 
cell analysis, cytometry, blood analysis, nucleic acids amplification, genetic map-
ping, enzymatic assays, peptide analysis, protein separation, toxicity analysis, and 
bioassays [42]. In the area of drug research, the LoC devices have gradually became 
significant with the prominence on cell targeting, clinical trials, drug synthesis, 
pharmaceutical formulations, and product management process [43]. The LoC 
devices are found promising in the analysis of drugs and determination of optimal 
dosages. This is especially useful for testing the synergistic effect of combined drugs 
[44]. In recent past, microfluidic LoCs presented an exclusive prospect to repli-
cate natural veins for testing nanoparticles as drug carriers for targeting cells or, 
moreover, presented opportunities for investigate in vitro metabolism of biological 
cultures [45].
Compactness, portability, modularity, embedded computing, automated sample 
handling, low electronic noise, limited power consumption, and straightforward 
integration of various components are some notable technical advantages of LoC 
devices [46]. Furthermore, LoC devices are capable of supporting a wide range of 
processes such as sampling, routing, transport, dispensing, and mixing, mostly 
with reduced moving or spinning mechanisms [47]. Due to their small size, the LoC 
devices offer precise fluidic transportation via the use of electrokinetics or micro-
pumping, efficient separation of the liquid samples, and precision in the measure-
ment of samples [48]. Likewise, the LoC devices can reduce the time of synthesis of 
a product and the time of analysis of a sample because of the small fluidic volumes 
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that they handle. LoC devices can also measure samples with greater precision, with 
their capability of controlling the chemical reactions through efficient control of 
the reactants concentration [49].
In the same way, the field of clinical medicine deeply benefited from micro-
fluidic LoC technology as it suites for disease modeling and drug screening [50], 
tests for observing pandemics [51], glucose monitoring, diabetic control, diagno-
sis of diseases, and numerous other tests [22, 52]. LoC devices enhance numer-
ous biomedical tests that entail mixing, analysis, and separation of samples, 
which usually consist of cell suspensions, nucleic acids, and proteins; analytical, 
electrical, or optical detection methods are also possible [53]. Key manufactur-
ing advantages that make microfluidic LoC technology reasonable are: achiev-
able mass production, affordable replacement cost, short time manufacture, 
simple quality tests, and broad range of supporting computer-aided design and 
simulation software tools [54]. However, the technical limitations such as size 
reduction, sample input rates, power consumption, chip reliability, and biocom-
patibility all still require further investigations in the design of microfluidic LoC 
technology [55].
5.  Research potential of mHealth-based microfluidic Lab-on-a-Chip 
technology for international public health security
In era of international public health catastrophe, academia, industry, the R&D 
community, and governments must be stimulated as an interconnected group 
to promptly determine the obligatory biomedical engineering and international 
public health interventions. Achieving significant acceleration in R&D related to 
international public health security requires significant amount of new directions 
because it is critical to use the best technology, investigation, and development 
to strengthen international public health defense. However, the simplicity and 
system integration provided by microfluidic LoC technology for the implementa-
tion of multiple tasks, such as sample preparation, separation, amplification, and 
detection, have largely extended their use in biomedical and international public 
health applications [56, 57]. Examples of their uses are immunoassays with plasma 
generation for electrochemical detection, infectious disease diagnostics based on 
platforms that integrate sample preparation, PCR, integrated valves for DNA-based 
diagnosis, quantification, and biochemical analysis for the evaluation and quality 
control of DNA, RNA, proteins, and cells together with fluorescence or similar 
visualization methods [58, 59].
Microfluidic LoC technology is an excellent choice for integrating mHealth-
based point-of-care devices in resource-limited settings, offering portable medi-
cal analysis without the need of costly and sophisticated equipment, and the fast 
obtention of results without involving an extensive knowledge of the diagnosis 
principle involved [60–64]. Several studies have proven the effectiveness of LoC 
devices as portable point-of-care diagnosis tools in the detection of infected 
microorganisms, biological analytes, and blood analysis [61, 62]. Microfluidic 
LoC systems can also be used for controlled, personalized drug delivery accord-
ing to patient’s response, extent of disease, and current conditions [63]. Besides, 
key advantages that mHealth-based microfluidic LoCs can offer for interna-
tional public health are facilitating early-stage accurate diagnosis, maintaining 
better communication and monitoring of patients, enabling better tracking of 
disease outbreaks, and improving the epidemiological surveillance of diseases, 
which are predominantly challenging problems for international public health 
security.
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6. Conclusion
It is widely discussed that microfluidic LoC technology has great potential 
to revolutionize the international public health field and possess the capability 
to give a boost to international public health security. There is a pressing need 
for new health technologies for diagnosing and treating avoidable international 
public health problems. mHealth-based microfluidic LoC technology still seem to 
be a dream especially in resource-limited settings. One of the biggest challenges 
in the field of mHealth-based microfluidic LoC is the translation from academic 
research to end-user products. While the field of microfluidic LoC technology has 
seen an exponential development in recent past, the launch of a commercialized 
platform that would revolutionize the concept of mHealth-based microfluidic LoC 
technology is still lacking. A bottleneck that hinders the adoption of microfluidic 
LoCs in international public health and mHealth applications remains due to the 
facility and skill requirement and knowledge gap. Despite barriers and challenging 
issues, many great opportunities are still waiting ahead. There are no “one size fits 
all” solutions for modeling complex international public health security problems 
“on a chip.” Tackling the international public health security challenges in a way 
that yields meaningful advances will therefore require bringing together groups 
with diverse expertise in biomedical engineering, synthetic biologist and chemist, 
microfluidic LoC technology professionals, international public health, and health 
security experts.
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